417 related articles for article (PubMed ID: 15531461)
1. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
[TBL] [Abstract][Full Text] [Related]
2. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
3. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH; Nagib N; Guthrie T
Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
[TBL] [Abstract][Full Text] [Related]
5. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
7. Quantification of analgesic use in children with sickle cell disease.
Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
[TBL] [Abstract][Full Text] [Related]
8. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
9. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
10. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
11. [Vaso-occlusive pain crises in children with sickle cell anemia].
Fournier-Charrière E
Soins Pediatr Pueric; 2007 Feb; (234):21-6. PubMed ID: 17338413
[No Abstract] [Full Text] [Related]
12. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
[TBL] [Abstract][Full Text] [Related]
13. [Emergencies in adults with sickle cell disease].
Godeau B
Bull Acad Natl Med; 2004; 188(3):507-15; discussion 515-7. PubMed ID: 15584659
[TBL] [Abstract][Full Text] [Related]
14. Patient-controlled analgesia with tramadol versus tramadol plus ketorolac.
Lepri A; Sia S; Catinelli S; Casali R; Novelli G
Minerva Anestesiol; 2006; 72(1-2):59-67. PubMed ID: 16407807
[TBL] [Abstract][Full Text] [Related]
15. The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.
Kalff A; Dowsing C; Grigg A
Br J Haematol; 2010 Jun; 149(5):768-74. PubMed ID: 20346014
[TBL] [Abstract][Full Text] [Related]
16. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
17. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
18. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
19. [Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].
Dickerhoff R; von Ruecker A
Klin Padiatr; 1995; 207(6):321-5. PubMed ID: 8569133
[TBL] [Abstract][Full Text] [Related]
20. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
